{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:39:11Z","timestamp":1791826751988,"version":"4.3.4"},"reference-count":95,"publisher":"Institute of Physiology of the Czech Academy of Sciences","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Physiol Res"],"published-print":{"date-parts":[[2020,3,27]]},"abstract":"<jats:p>Since the recognition of angiotensin-converting enzyme inhibitors (ACEIs)-induced cough, drug has been considered as a potential cause of chronic cough. This review presents recent knowledge on drug-induced coughs in patients with chronic cough. The focus is placed on ACEIs, for which there are a multitude of studies documenting their associations with cough. Additional drugs are discussed for which there are reports of cough as a side effect of treatment, and the potential mechanisms of these effects are discussed.<\/jats:p>","DOI":"10.33549\/physiolres.934406","type":"journal-article","created":{"date-parts":[[2020,3,29]],"date-time":"2020-03-29T21:58:11Z","timestamp":1585519091000},"page":"S81-S92","source":"Crossref","is-referenced-by-count":29,"title":["Drug-Induced Cough"],"prefix":"10.33549","author":[{"given":"J.","family":"Shim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.-J.","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ewha Womans University College of Medicine, Seoul, Korea. swj0126@amc.seoul.kr"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.H.","family":"Morice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"19169","published-online":{"date-parts":[[2020,3,27]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"AGARWAL A, AZIM A, AMBESH S, BOSE N, DHIRAJ S, SAHU D, SINGH U: Salbutamol, beclomethasone or sodium chromoglycate suppress coughing induced by iv fentanyl. Can J Anaesth 50: 297-300, 2003. https:\/\/doi.org\/10.1007\/BF03017801","DOI":"10.1007\/bf03017801"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"AHREN B, JOHNSON SL, STEWART M, CIRKEL DT, YANG F, PERRY C, FEINGLOS MN, HARMONY STUDY GROUP: HARMONY 3: 104-week randomized, double-blind, placebo- and active-controlled trial assessing the efficacy and safety of albiglutide compared with placebo, sitagliptin, and glimepiride in patients with type 2 diabetes taking metformin. Diabetes Care 37: 2141-2148, 2014. https:\/\/doi.org\/10.2337\/dc14-0024","DOI":"10.2337\/dc14-0024"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"AI Q, HU Y, WANG Y, WU S, QIN Z, WANG J, WANG G, ZHANG J, AN M: Pentazocine pretreatment suppresses fentanyl-induced cough. Pharmacol Rep 62: 747-750, 2010. https:\/\/doi.org\/10.1016\/S1734-1140(10)70333-9","DOI":"10.1016\/s1734-1140(10)70333-9"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"ALHARBI FF, KHOLOD AAV, SOUVEREIN PC, MEYBOOM RH, DE GROOT MCH, DE BOER A, KLUNGEL OH. The impact of age and sex on the reporting of cough and angioedema with renin-angiotensin system inhibitors: a case\/noncase study in VigiBase. Fundam Clin Pharmacol 31: 676-684, 2017. https:\/\/doi.org\/10.1111\/fcp.12313","DOI":"10.1111\/fcp.12313"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"ARJONA FERREIRA JC, CORRY D, MOGENSEN CE, SLOAN L, XU L, GOLM GT, GONZALEZ EJ, DAVIES MJ, KAUFMAN KD, GOLDSTEIN BJ: Efficacy and safety of sitagliptin in patients with type 2 diabetes and ESRD receiving dialysis: a 54-week randomized trial. Am J Kidney Dis 61: 579-587, 2013. https:\/\/doi.org\/10.1053\/j.ajkd.2012.11.043","DOI":"10.1053\/j.ajkd.2012.11.043"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"BAKER-SMITH CM, BENJAMIN DK, CALIFF RM, MURPHY MD, LI JS, SMITH PB: Cough in pediatric patients receiving angiotensin-converting enzyme inhibitor therapy or angiotensin receptor blocker therapy in randomized controlled trials. Clin Pharmacol Ther 87: 668-671, 2010. https:\/\/doi.org\/10.1038\/clpt.2009.231","DOI":"10.1038\/clpt.2009.231"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"BARANIUK JN, JAMIESON MJ: Rhinorrhea, cough and fatigue in patients taking sitagliptin. Allergy Asthma Clin Immunol 6: 8, 2010. https:\/\/doi.org\/10.1186\/1710-1492-6-8","DOI":"10.1186\/1710-1492-6-8"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"BART BA, ERTL G, HELD P, KUCH J, MAGGIONI AP, MCMURRAY J, MICHELSON EL, ROULEAU JL, WARNER L, STEVENSON K, SWEDBERG J, YOUNG B, YUSUF S, SELLERS MA, GRANGER CB, CALIFF RM, PFEFFER MA: Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry. Eur Heart J 20: 1182-1190, 1999. https:\/\/doi.org\/10.1053\/euhj.1998.1481","DOI":"10.1053\/euhj.1998.1481"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"BERTRAND ME: Provision of cardiovascular protection by ACE inhibitors: a review of recent trials. Curr Med Res Opin 20: 1559-1569, 2004. https:\/\/doi.org\/10.1185\/030079904X4185","DOI":"10.1185\/030079904x4185"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"BOHRER HF, FLEISCHER F, WERNING P: Tussive effect of a fentanyl bolus administered through a central venous catheter. Anaesthesia 45: 18-21, 1990. https:\/\/doi.org\/10.1111\/j.1365-2044.1990.tb14496.x","DOI":"10.1111\/j.1365-2044.1990.tb14496.x"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"BRUGTS JJ, ARIMA H, REMME W, BERTRAND M, FERRARI R, FOX K, DINICOLANTONIO J, MACMAHON S, CHALMERS J, ZIJLSTRA F, CALISKAN K, SIMOONS ML, MOURAD JJ, BOERSMA E, AKKERHUIS KM: The incidence and clinical predictors of ACE-inhibitor induced dry cough by perindopril in 27,492 patients with vascular disease. Int J Cardiol 176: 718-723, 2014. https:\/\/doi.org\/10.1016\/j.ijcard.2014.07.108","DOI":"10.1016\/j.ijcard.2014.07.108"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"CAI LY, CAI Z, LU J, ZHANG Y, LIU P: The efficacy and safety of vildagliptin in patients with type 2 diabetes: a meta-analysis of randomized clinical trials. J Clin Pharm Ther 37: 386-398, 2012. https:\/\/doi.org\/10.1111\/j.1365-2710.2011.01323.x","DOI":"10.1111\/j.1365-2710.2011.01323.x"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"CALDEIRA D, DAVID C, SAMPAIO C: Tolerability of angiotensin-receptor blockers in patients with intolerance to angiotensin-converting enzyme inhibitors: a systematic review and meta-analysis. Am J Cardiovasc Drugs 12: 263-277, 2012. https:\/\/doi.org\/10.1007\/BF03261835","DOI":"10.1007\/bf03261835"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"CHARBONNEL B, KARASIK A, LIU J, WU M, MEININGER G, GROUP SITAGLIPTIN STUDY: Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone', Diabetes Care 29: 2638-2643, 2006.https:\/\/doi.org\/10.2337\/dc06-0706","DOI":"10.2337\/dc06-0706"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"DASHTI-KHAVIDAKI S, FAGHIHI T, AHMADI F, KHALILI H: Cough induced by losartan with resolution after substitution with enalapril. Clin Ther 30: 548-551, 2008. https:\/\/doi.org\/10.1016\/j.clinthera.2008.03.003","DOI":"10.1016\/j.clinthera.2008.03.003"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"DICPINIGAITIS PV: Angiotensin-converting enzyme inhibitor-induced cough: ACCP evidence-based clinical practice guidelines. Chest 129: 169-73, 2006. https:\/\/doi.org\/10.1378\/chest.129.1_suppl.169S","DOI":"10.1378\/chest.129.1_suppl.169s"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"DOUCET J, CHACRA A, MAHEUX P, LU J, HARRIS S, OSENSTOCK R: Efficacy and safety of saxagliptin in older patients with type 2 diabetes mellitus. Curr Med Res Opin 27: 863-869, 2011. https:\/\/doi.org\/10.1185\/03007995.2011.554532","DOI":"10.1185\/03007995.2011.554532"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"DUBE SK, RATH GP: Cough and bronchospasm after rapid intravenous administration of phenytoin. J Neurosurg Anesthesiol 24: 239-240, 2012. https:\/\/doi.org\/10.1097\/ANA.0b013e318259b46a","DOI":"10.1097\/ana.0b013e318259b46a"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"DYKEWICZ MS: Cough and angioedema from angiotensin-converting enzyme inhibitors: new insights into mechanisms and management. Curr Opin Allergy Clin Immunol 4: 267-270, 2004. https:\/\/doi.org\/10.1097\/01.all.0000136759.43571.7f","DOI":"10.1097\/01.all.0000136759.43571.7f"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"EDWARDS CR, PADFIELD PL: Angiotensin-converting enzyme inhibitors: past, present, and bright future. Lancet 1: 30-34, 1985. https:\/\/doi.org\/10.1016\/S0140-6736(85)90975-4","DOI":"10.1016\/s0140-6736(85)90975-4"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"EL-HASHIM AZ, AMINES A: The role of substance P and bradykinin in the cough reflex and bronchoconstriction in guinea-pigs. Eur J Pharmacol 513: 125-133, 2005. https:\/\/doi.org\/10.1016\/j.ejphar.2005.02.007","DOI":"10.1016\/j.ejphar.2005.02.007"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"ELLI A, AROLDI A, MONTAGNINO G, TARANTINO A, PONTICELLI C: Mycophenolate mofetil and cough. Transplantation 66: 409, 1998. https:\/\/doi.org\/10.1097\/00007890-199808150-00026","DOI":"10.1097\/00007890-199808150-00026"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"ENGEL SS, ROUND E, GOLM GT, KAUFMAN KD, GOLDSTEIN BJ: Safety and tolerability of sitagliptin in type 2 diabetes: pooled analysis of 25 clinical studies. Diabetes Ther 4: 119-145, 2013. https:\/\/doi.org\/10.1007\/s13300-013-0024-0","DOI":"10.1007\/s13300-013-0024-0"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"FAHIM A, MORICE AH: Heightened cough sensitivity secondary to latanoprost. Chest 136: 1406-07, 2009. https:\/\/doi.org\/10.1378\/chest.09-0070","DOI":"10.1378\/chest.09-0070"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"FAZAL K, PERERA G, KHONDOKER M, HOWARD R, STEWART R: Associations of centrally acting ACE inhibitors with cognitive decline and survival in Alzheimer's disease BJPsych open 3: 158-164, 2017. https:\/\/doi.org\/10.1192\/bjpo.bp.116.004184","DOI":"10.1192\/bjpo.bp.116.004184"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"HALLBERG P, PERSSON M, AXELSSON T, CAVALLI M, NORLING P, JOHANSSON JE, YUE YJ, MAGNUSSON PK, WADELIUS C, ERIKSSON N, WADELIUS M: Genetic variants associated with angiotensin-converting enzyme inhibitor-induced cough: a genome-wide association study in a Swedish population. Pharmacogenomics 18: 201-213, 2017. https:\/\/doi.org\/10.2217\/pgs-2016-0184","DOI":"10.2217\/pgs-2016-0184"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"HEWITT M, ADAMS G, MAZZONE SB, MORI N, YU L, CANNING BJ: Pharmacology of bradykinin-evoked coughing in guinea pigs. J Pharmacol Exp Ther 357: 620-628, 2016. https:\/\/doi.org\/10.1124\/jpet.115.230383","DOI":"10.1124\/jpet.115.230383"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"HOWAIZI M, DELAFOSSE C: Omeprazole-induced intractable cough. Ann Pharmacother 37: 1607-1609, 2003. https:\/\/doi.org\/10.1345\/aph.1D185","DOI":"10.1345\/aph.1d185"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"HUGHES J, LOCKHART J, JOYCE A: Do calcium antagonists contribute to gastro-oesophageal reflux disease and concomitant noncardiac chest pain? Br J Clin Pharmacol 64: 83-89, 2007. https:\/\/doi.org\/10.1111\/j.1365-2125.2007.02851.x","DOI":"10.1111\/j.1365-2125.2007.02851.x"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"HUMBERT X, ALEXANDRE J, SASSIER M, DEFAULT A, GOURAUD A, YELEHE-OKOUMA M, PUDDU PE, FEDRIZZI S: Long delay to onset of ACE inhibitors-induced cough: Reason of difficult diagnosis in primary care? Eur J Intern Med 37: 50-51, 2017. https:\/\/doi.org\/10.1016\/j.ejim.2016.10.006","DOI":"10.1016\/j.ejim.2016.10.006"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"IGNJATOVIC T, TAN F, BROVKOVYCH V, SKIDGEL RA, ERDOS EG: Novel mode of action of angiotensin I converting enzyme inhibitors: direct activation of bradykinin B1 receptor. J Biol Chem 277: 16847-16852, 2002. https:\/\/doi.org\/10.1074\/jbc.M200355200","DOI":"10.1074\/jbc.m200355200"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"IRWIN RS, FRENCH CL, CHANG AB, ALTMAN KW, ADAMS TM, AZOULAY E, BARKER AF, BIRRING SS, BLACKHALL F, BOLSER DC: Classification of cough as a symptom in adults and management algorithms: CHEST guideline and expert panel report. Chest 153: 196-209, 2018. https:\/\/doi.org\/10.1016\/j.chest.2017.10.016","DOI":"10.1016\/j.chest.2020.01.042"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"JAFAR TH, SCHMID CH, LANDA M, GIATRAS I, TOTO R, REMUZZI G, MASCHIO G, BRENNER BM, KAMPER A, ZUCCHELLI P, BECKER G, HIMMELMANN A, BANNISTER K, LANDAIS P, SHAHINFAR S, DE JONG PE, DE ZEEUW D, LAU J, LEVEY AS: Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Ann Intern Med, 135: 73-87, 2001. https:\/\/doi.org\/10.7326\/0003-4819-135-2-200107170-00007","DOI":"10.7326\/0003-4819-135-2-200107170-00007"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"KAHRILAS PJ, HOWDEN CW, HUGHES N, MOLLOY-BLAND M: Response of chronic cough to acid-suppressive therapy in patients with gastroesophageal reflux disease. Chest 143: 605-612, 2013. https:\/\/doi.org\/10.1378\/chest.12-1788","DOI":"10.1378\/chest.12-1788"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"KAMEI J, NAKANISHI Y, ASATO M, IKEDA H: Fentanyl enhances the excitability of rapidly adapting receptors to cause cough via the enhancement of histamine release in the airways. Cough 9: 3, 2013. https:\/\/doi.org\/10.1186\/1745-9974-9-3","DOI":"10.1186\/1745-9974-9-3"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"KAUFMAN J, CASANOVA JE, RIENDL P, SCHLUETER DP: Bronchial hyperreactivity and cough due to angiotensin-converting enzyme inhibitors. Chest 95: 544-548, 1989. https:\/\/doi.org\/10.1378\/chest.95.3.544","DOI":"10.1378\/chest.95.3.544"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"KAUFMAN J, SCHMITT S, BARNARD J, BUSSE W: Angiotensin-converting enzyme inhibitors in patients with bronchial responsiveness and asthma. Chest 101: 922-925, 1992. https:\/\/doi.org\/10.1378\/chest.101.4.922","DOI":"10.1378\/chest.101.4.922"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"KIM NH, YU T, LEE DH: The nonglycemic actions of dipeptidyl peptidase-4 inhibitors. Biomed Res Int 2014: 368703, 2014. https:\/\/doi.org\/10.1155\/2014\/368703","DOI":"10.1155\/2014\/368703"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"KIM YS, PARK HS, SUNWOO S, BYEON JJ, SONG YM, SEO HG, KIM CH, CHEON KS, YOO SM, LEE JK, GROUP KOREA POST-MARKETING SURVEILLANCE RESEARCH: Short-term safety and tolerability of antihypertensive agents in Korean patients: an observational study. Pharmacoepidemiol Drug Saf 9: 603-609, 2000. https:\/\/doi.org\/10.1002\/pds.554","DOI":"10.1002\/pds.554"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"KLIMKO PG, SHARIF NA: Discovery, characterization and clinical utility of prostaglandin agonists for the treatment of glaucoma. Br J Pharmacol 176: 1051-1058, 2019. https:\/\/doi.org\/10.1111\/bph.14327","DOI":"10.1111\/bph.14327"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"LAINEZ MJ, FREITAG FG, PFEIL J, ASCHER S, OLSON WH, SCHWALEN S: Time course of adverse events most commonly associated with topiramate for migraine prevention. Eur J Neurol 14: 900-906, 2007. https:\/\/doi.org\/10.1111\/j.1468-1331.2007.01869.x","DOI":"10.1111\/j.1468-1331.2007.01869.x"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"LEE YJ, TSAI JC: Angiotensin-converting enzyme gene insertion\/deletion, not bradykinin B2 receptor -58T\/C gene polymorphism, associated with angiotensin-converting enzyme inhibitor-related cough in Chinese female patients with non-insulin-dependent diabetes mellitus. Metabolism 50: 1346-1350, 2001. https:\/\/doi.org\/10.1053\/meta.2001.27212","DOI":"10.1053\/meta.2001.27212"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"LEHRKE M, MARX N, PATEL S, SECK T, CROWE S, CHENG K, VON EYNATTEN M, JOHANSEN OE: Safety and tolerability of linagliptin in patients with Type 2 diabetes: A comprehensive pooled analysis of 22 placebo-controlled studies. Clin Ther 36: 1130-1146, 2014. https:\/\/doi.org\/10.1016\/j.clinthera.2014.06.008","DOI":"10.1016\/j.clinthera.2014.06.008"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"LI EC, HERAN BS, WRIGHT JM: Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension. Cochrane Database Syst Rev CD009096, 2014. https:\/\/doi.org\/10.1002\/14651858.CD009096.pub2","DOI":"10.1002\/14651858.cd009096.pub2"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"LI YF, ZHU XM, LIU F, XIAO CS, BIAN YF, LI H, CAI J, LI RS, YANG XC: Angiotensin-converting enzyme (ACE) gene insertion\/deletion polymorphism and ACE inhibitor-related cough: a meta-analysis. PLoS One 7: e37396, 2012. https:\/\/doi.org\/10.1371\/journal.pone.0037396","DOI":"10.1371\/journal.pone.0037396"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"MAGGIONI F, MAMPRESO E, MAINARDI F, LISOTTO C, MALVINDI ML, ZANCHIN G: Topiramate-induced intractable cough during migraine prophylaxis. Headache 50: 301-304, 2010. https:\/\/doi.org\/10.1111\/j.1526-4610.2009.01515.x","DOI":"10.1111\/j.1526-4610.2009.01515.x"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"MAHMOUDPOUR SH, VELUCHAMY A, SIDDIQUI MK, ASSELBERGS FW, SOUVEREIN PC, DE KEYSER CE, HOFMAN A, LANG CC, DONEY AS, STRICKER BH, DE BOER A, MAITLAND-VAN DER ZEE AH, PALMER CN: Meta-analysis of genome-wide association studies on the intolerance of angiotensin-converting enzyme inhibitors. Pharmacogenet Genomics 27: 112-119, 2017. https:\/\/doi.org\/10.1097\/FPC.0000000000000264","DOI":"10.1097\/fpc.0000000000000264"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"MATCHAR DB, MCCRORY DC, ORLANDO LA, PATEL MR, PATEL UD, PATWARDHAN MB, POWERSB, SAMSA GP, GRAY RN: Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension. Ann Intern Med 148: 16-29, 2008. https:\/\/doi.org\/10.7326\/0003-4819-148-1-200801010-00189","DOI":"10.7326\/0003-4819-148-1-200801010-00189"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"MCDOWELL SE, COLEMAN JJ, FERNER RE: Systematic review and meta-analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine. BMJ 332: 1177-1181, 2006. https:\/\/doi.org\/10.1136\/bmj.38803.528113.55","DOI":"10.1136\/bmj.38803.528113.55"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"MEDFORD AR: A 54 year-old man with a chronic cough \u2013 Chronic cough: don't forget drug-induced causes. Prim Care Respir J 21: 347-348, 2012. https:\/\/doi.org\/10.4104\/pcrj.2012.00078","DOI":"10.4104\/pcrj.2012.00078"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"MORICE AH, JAKES AD, FARUQI S, BIRRING SS, MCGARVEY L, CANNING BJ, SMITH JA, PARKER SM, CHUNG KF, LAI K, PAVORD ID, VAN DEN BERG J, SONG WJ, MILLQVIST E, FARRELL MJ, MAZZONE SB, DICPINIGAITIS P, REGISTRY CHRONIC COUGH: A worldwide survey of chronic cough: a manifestation of enhanced somatosensory response. Eur Respir J 44: 1149-1155, 2014. https:\/\/doi.org\/10.1183\/09031936.00217813","DOI":"10.1183\/09031936.00217813"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"MORICE AH, LOWRY R, BROWN MJ, HIGENBOTTAM T: Angiotensin-converting enzyme and the cough reflex. Lancet 2: 1116-8, 1987. https:\/\/doi.org\/10.1016\/S0140-6736(87)91547-9","DOI":"10.1016\/s0140-6736(87)91547-9"},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"MORICE AH, MCGARVEY L, PAVORD I: Recommendations for the management of cough in adults. Thorax 61 (Suppl 1): i1-24, 2006. https:\/\/doi.org\/10.1136\/thx.2006.065144","DOI":"10.1136\/thx.2006.065144"},{"key":"ref53","doi-asserted-by":"publisher","unstructured":"MORICE AH, MILLQVIST E, BELVISI MG, BIEKSIENE K, BIRRING SS, CHUNG KF, DAL NEGRO RW, DICPINIGAITIS P, KANTAR A, MCGARVEY LP: Expert opinion on the cough hypersensitivity syndrome in respiratory medicine. Eur Respir J 44: 1132-1148, 2014. https:\/\/doi.org\/10.1183\/09031936.00218613","DOI":"10.1183\/09031936.00218613"},{"key":"ref54","doi-asserted-by":"publisher","unstructured":"MORICE AH, MILLQVIST E, BIEKSIENE K, BIRRING SS, DICPINIGAITIS P, RIBAS CD, BOON MH, KANTAR A, LAI K, MCGARVEY L, RIGAU D, SATIA I, SMITH J, SONG JW, TONIA T, VAN DEN BERG JWK, VAN MANEN MJG, ZACHARASIEWICZ A: ERS guidelines on the diagnosis and treatment of chronic cough in adults and children. Eur Respir J 55: pii:1901136, 2020. https:\/\/doi.org\/10.1183\/13993003.01136-2019","DOI":"10.1183\/13993003.01136-2019"},{"key":"ref55","doi-asserted-by":"publisher","unstructured":"MORIMOTO T, GANDHI TK, FISKIO JM, SEGER AC, SO JW, COOK EF, FUKUI T, BATES DW: An evaluation of risk factors for adverse drug events associated with angiotensin-converting enzyme inhibitors', J Eval Clin Pract 10: 499-509, 2004. https:\/\/doi.org\/10.1111\/j.1365-2753.2003.00484.x","DOI":"10.1111\/j.1365-2753.2003.00484.x"},{"key":"ref56","doi-asserted-by":"publisher","unstructured":"MUKAE S, AOKI S, ITOH S, IWATA T, UEDA H, KATAGIRI T: Bradykinin B2 receptor gene polymorphism is associated with angiotensin-converting enzyme inhibitor-related cough', Hypertension 36: 127-131, 2000. https:\/\/doi.org\/10.1161\/01.HYP.36.1.127","DOI":"10.1161\/01.hyp.36.1.127"},{"key":"ref57","doi-asserted-by":"publisher","unstructured":"MUKAE S, ITOH S, AOKI S, IWATA T, NISHIO K, SATO R, KATAGIRI T: Association of polymorphisms of the renin-angiotensin system and bradykinin B2 receptor with ACE-inhibitor-related cough. J Hum Hypertens 16: 857-863, 2002. https:\/\/doi.org\/10.1038\/sj.jhh.1001486","DOI":"10.1038\/sj.jhh.1001486"},{"key":"ref58","doi-asserted-by":"publisher","unstructured":"NASCIMENTO FA, TAKESHITA BT, KOWACS PA: Phenytoin-induced isolated chronic, nocturnal dry cough. Epilepsy Behav Case Rep 5: 44-45, 2016. https:\/\/doi.org\/10.1016\/j.ebcr.2016.03.002","DOI":"10.1016\/j.ebcr.2016.03.002"},{"key":"ref59","doi-asserted-by":"publisher","unstructured":"NICHOL G, NIX A, BARNES PJ, CHUNG KF: Prostaglandin F2 alpha enhancement of capsaicin induced cough in man: modulation by beta 2 adrenergic and anticholinergic drugs. Thorax 45: 694-698, 1990. https:\/\/doi.org\/10.1136\/thx.45.9.694","DOI":"10.1136\/thx.45.9.694"},{"key":"ref60","doi-asserted-by":"publisher","unstructured":"NIKPOOR B, DUAN QL, ROULEAU GA: Acute adverse reactions associated with angiotensin-converting enzyme inhibitors: genetic factors and therapeutic implications. Expert Opin Pharmacother 6: 1851-1856, 2005. https:\/\/doi.org\/10.1517\/14656566.6.11.1851","DOI":"10.1517\/14656566.6.11.1851"},{"key":"ref61","doi-asserted-by":"publisher","unstructured":"O'CONNELL F, THOMAS WE, PRIDE NB, FULLER RW: Capsaicin cough sensitivity decreases with successful treatment of chronic cough. Am J Respir Crit Care Med 150: 374-380, 1994. https:\/\/doi.org\/10.1164\/ajrccm.150.2.8049818","DOI":"10.1164\/ajrccm.150.2.8049818"},{"key":"ref62","doi-asserted-by":"publisher","unstructured":"OS I, BRATLAND B, DAHLOF B, GISHOLT K, SYVERTSEN JO, TRETLI S: Female preponderance for lisinopril-induced cough in hypertension. Am J Hypertens 7: 1012-1015, 1994. https:\/\/doi.org\/10.1093\/ajh\/7.11.1012","DOI":"10.1093\/ajh\/7.11.1012"},{"key":"ref63","doi-asserted-by":"publisher","unstructured":"PACKARD KA, WURDEMAN RL, AROUNI AJ: ACE inhibitor-induced bronchial reactivity in patients with respiratory dysfunction. Ann Pharmacother 36: 1058-1067, 2002. https:\/\/doi.org\/10.1345\/aph.1A332","DOI":"10.1345\/aph.1a332"},{"key":"ref64","doi-asserted-by":"publisher","unstructured":"PARK HK, OH SY, KIM TB, BAHN JW, SHIN ES, LEE JE, OH HB, KIM YK, PARK T, CHO SH, MIN KU, KIM YY: Association of genetic variations in neurokinin-2 receptor with enhanced cough sensitivity to capsaicin in chronic cough. Thorax 61: 1070-1075, 2006. https:\/\/doi.org\/10.1136\/thx.2005.054429","DOI":"10.1136\/thx.2005.054429"},{"key":"ref65","doi-asserted-by":"publisher","unstructured":"PARMAR MS: Exacerbation of asthma secondary to fentanyl transdermal patch. BMJ Case Rep 2009: pii: bcr10.2008.1062, 2009. https:\/\/doi.org\/10.1136\/bcr.10.2008.1062","DOI":"10.1136\/bcr.10.2008.1062"},{"key":"ref66","doi-asserted-by":"publisher","unstructured":"RAVID D, LISHNER M, LANG R, RAVID M: Angiotensin-converting enzyme inhibitors and cough: a prospective evaluation in hypertension and in congestive heart failure. J Clin Pharmacol 34: 1116-1120, 1994. https:\/\/doi.org\/10.1002\/j.1552-4604.1994.tb01989.x","DOI":"10.1002\/j.1552-4604.1994.tb01989.x"},{"key":"ref67","doi-asserted-by":"publisher","unstructured":"REICHE I, TROGER U, MARTENS-LOBENHOFFER J, KANDULSKI A, NEUMANN H, MALFERTHEINER P. BODE-BOGER SM: Omeprazole-induced cough in a patient with gastroesophageal reflux disease. Eur J Gastroenterol Hepatol 22: 880-882, 2010. https:\/\/doi.org\/10.1097\/MEG.0b013e3283320129","DOI":"10.1097\/meg.0b013e3283320129"},{"key":"ref68","unstructured":"REISIN L, SCHNEEWEISS A: Complete spontaneous remission of cough induced by ACE inhibitors during chronic therapy in hypertensive patients. J Hum Hypertens 6: 333-335, 1992."},{"key":"ref69","doi-asserted-by":"publisher","unstructured":"SALEH AJ, ZHANG L, HADI SM, OUYANG W: A priming dose of intravenous ketamine-dexmedetomidine suppresses fentanyl-induced coughing: a double-blind, randomized, controlled study. Ups J Med Sci 119: 333-337, 2014. https:\/\/doi.org\/10.3109\/03009734.2014.968270","DOI":"10.3109\/03009734.2014.968270"},{"key":"ref70","doi-asserted-by":"publisher","unstructured":"SATO A, FUKUDA S: A prospective study of frequency and characteristics of cough during ACE inhibitor treatment. Clin Exp Hypertens. 37: 563-568, 2015. https:\/\/doi.org\/10.3109\/10641963.2015.1026040","DOI":"10.3109\/10641963.2015.1026040"},{"key":"ref71","doi-asserted-by":"publisher","unstructured":"SCHNABEL AK, DALHOFF S, BAUERFEIND J, GROSS WL: Sustained cough in methotrexate therapy for rheumatoid arthritis. Clin Rheumatol 15: 277-282, 1996. https:\/\/doi.org\/10.1007\/BF02229707","DOI":"10.1007\/bf02229707"},{"key":"ref72","doi-asserted-by":"publisher","unstructured":"SEKIZAWA K, EBIHARA T, SASAKI H: Role of substance P in cough during bronchoconstriction in awake guinea pigs. Am J Respir Crit Care Med 151: 815-821, 1995. https:\/\/doi.org\/10.1164\/ajrccm.151.3.7533603","DOI":"10.1164\/ajrccm\/151.3_pt_1.815"},{"key":"ref73","doi-asserted-by":"publisher","unstructured":"SEMPLE PF, HERD GW: Cough and wheeze caused by inhibitors of angiotensin-converting enzyme. N Engl J Med 314: 61, 1986. https:\/\/doi.org\/10.1056\/NEJM198601023140119","DOI":"10.1056\/nejm198601023140119"},{"key":"ref74","doi-asserted-by":"publisher","unstructured":"SESOKO S, KANEKO Y: Cough associated with the use of captopril. Arch Intern Med 145: 1524-1524, 1985. https:\/\/doi.org\/10.1001\/archinte.145.8.1524","DOI":"10.1001\/archinte.1985.00360080206033"},{"key":"ref75","doi-asserted-by":"publisher","unstructured":"SHIOBARA T, CHIBANA K, WATANABE T, ARAI R, HORIGANE Y, NAKAMURA Y, HAYASHI Y, SHIMIZU Y, TAKEMASA A, ISHII Y: Dipeptidyl peptidase-4 is highly expressed in bronchial epithelial cells of untreated asthma and it increases cell proliferation along with fibronectin production in airway constitutive cells. Respir Res 17: 28, 2016. https:\/\/doi.org\/10.1186\/s12931-016-0342-7","DOI":"10.1186\/s12931-016-0342-7"},{"key":"ref76","doi-asserted-by":"publisher","unstructured":"SHUYING L, PING L, JUAN N, DONG L: Different interventions in preventing opioid-induced cough: a meta-analysis. J Clin Anesth 34: 440-447, 2016. https:\/\/doi.org\/10.1016\/j.jclinane.2016.05.034","DOI":"10.1016\/j.jclinane.2016.05.034"},{"key":"ref77","doi-asserted-by":"publisher","unstructured":"SILBERSTEIN SD: Topiramate in migraine prevention: a 2016 perspective. Headache 57: 165-178, 2017. https:\/\/doi.org\/10.1111\/head.12997","DOI":"10.1111\/head.12997"},{"key":"ref78","doi-asserted-by":"publisher","unstructured":"SMITH J, ALLMAN D, BADRI H, MILLER R, MORRIS J, SATIA I, WOOD A, TROWER M: The neurokinin-1 receptor antagonist orvepitant is a novel antitussive therapy for chronic refractory cough: results from a Phase 2 Pilot Study (VOLCANO-1). Chest 157: 111-118, 2020. https:\/\/doi.org\/10.1016\/j.chest.2019.08.001","DOI":"10.1016\/j.chest.2019.08.001"},{"key":"ref79","doi-asserted-by":"publisher","unstructured":"SONG, DJ, SONG WJ, KWON JW, KIMGW, KIM MA, KIM MY, KIM MH, KIM SH, KIM ST, KIM SH, KIM JK, KIM JH, KIM HJ, KIM HB, PARK KH, YOON JK, LEE BJ, LEE SE, LEE YM, LEE YJ, LIM, KH, JEON YH, JO EJ, JEE, YK, JIN HJ, CHOI SH, HUR GY, CHO SH, KIM SH, LIM DH: KAAACI Evidence-based clinical practice guidelines for chronic cough in adults and children in Korea. Allergy Asthma Immunol Res 10: 591-613, 2018. https:\/\/doi.org\/10.4168\/aair.2018.10.6.591","DOI":"10.1016\/s1470-2045(19)30565-0"},{"key":"ref80","doi-asserted-by":"publisher","unstructured":"SONG WJ, MORICE AH: Cough hypersensitivity syndrome: a few more steps forward. Allergy Asthma Immunol Res 9: 394-402, 2017. https:\/\/doi.org\/10.4168\/aair.2017.9.5.394","DOI":"10.4168\/aair.2017.9.5.394"},{"key":"ref81","doi-asserted-by":"crossref","unstructured":"SONG W J, WON HK, AN J, KANG SY, JO EJ, CHANG YS, LEE BJ, CHO SH: Chronic cough in the elderly. Pulm Pharmacol Ther 56: 63-68, 2019. https:\/\/doi.org\/10.1016\/j.pupt.2019.03.010","DOI":"10.1016\/j.pupt.2019.03.010"},{"key":"ref82","doi-asserted-by":"publisher","unstructured":"STONE RP, BARNES J, FULLER RW: Contrasting effects of prostaglandins E2 and F2 alpha on sensitivity of the human cough reflex. J Appl Physiol 73: 649-653, 1992. https:\/\/doi.org\/10.1152\/jappl.1992.73.2.649","DOI":"10.1152\/jappl.1992.73.2.649"},{"key":"ref83","doi-asserted-by":"publisher","unstructured":"TOSUN E, TOPALOGLU O, AKKALYONCU B: As a rare cause of drug-induced cough: topiramate. Acta Neurol Belg 112: 217-220, 2012. https:\/\/doi.org\/10.1007\/s13760-012-0016-2","DOI":"10.1007\/s13760-012-0016-2"},{"key":"ref84","doi-asserted-by":"crossref","unstructured":"TRIFILIEFF A, DA SILVA A, GIES JP: Kinins and respiratory tract diseases. Eur Respir J 6: 576-587, 1993.","DOI":"10.1183\/09031936.93.06040576"},{"key":"ref85","unstructured":"TSOU CH, LUK HN, CHIANG SC, HSIN ST, WANG JH: Fentanyl-induced coughing and airway hyperresponsiveness. Acta Anaesthesiol Sin 40: 165-172, 2002."},{"key":"ref86","doi-asserted-by":"publisher","unstructured":"UJIIE Y, SEKIZAWA K, AIKAWA T, SASAKI H: Evidence for substance P as an endogenous substance causing cough in guinea pigs. Am J Respir Crit Care Med 148: 1628-1632, 1993. https:\/\/doi.org\/10.1164\/ajrccm\/148.6_Pt_1.1628","DOI":"10.1164\/ajrccm\/148.6_pt_1.1628"},{"key":"ref87","doi-asserted-by":"publisher","unstructured":"VEGTER S, BOER P, VAN DIJK KW, VISSER S: The effects of antitussive treatment of ACE inhibitor-induced cough on therapy compliance: a prescription sequence symmetry analysis. Drug Safety 36: 435-439, 2013. https:\/\/doi.org\/10.1007\/s40264-013-0024-z","DOI":"10.1007\/s40264-013-0024-z"},{"key":"ref88","doi-asserted-by":"publisher","unstructured":"VISSER LE, STRICKER BH, VELDEN JD, PAES AH, BAKKER A: Angiotensin converting enzyme inhibitor associated cough: a population-based case-control study. J Clin Epidemiol 48: 851-857, 1995. https:\/\/doi.org\/10.1016\/0895-4356(94)00231-E","DOI":"10.1016\/0895-4356(94)00231-e"},{"key":"ref89","doi-asserted-by":"publisher","unstructured":"VUKADINOVIC D, VUKADINOVIC AN, LAVALL D, LAUFS U, WAGENPFEIL S, BOHM M: Rate of cough during treatment with angiotensin-converting enzyme inhibitors: a meta-analysis of randomized placebo-controlled trials. Clin Pharmacol Ther 105: 652-660, 2019. https:\/\/doi.org\/10.1002\/cpt.1018","DOI":"10.1002\/cpt.1018"},{"key":"ref90","doi-asserted-by":"publisher","unstructured":"WILLIAMS-HERMAN D, ENGEL SS, ROUND E, JOHNSONJ, GOLM GT, MUSSER BJ, DAVIES MJ, KAUFMAN KD, GOLDSTEIN BJ: Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes. BMC Endocr Disord 10: 7, 2010. https:\/\/doi.org\/10.1186\/1472-6823-10-7","DOI":"10.1186\/1472-6823-10-7"},{"key":"ref91","doi-asserted-by":"publisher","unstructured":"WOO SW, BANG S, CHUNG MW, JIN SK, KIMYS, LEE SH: Lack of association between ACE and bradykinin B2 receptor gene polymorphisms and ACE inhibitor-induced coughing in hypertensive Koreans. J Clin Pharm Ther 34: 561-567, 2009. https:\/\/doi.org\/10.1111\/j.1365-2710.2009.01028.x","DOI":"10.1111\/j.1365-2710.2009.01028.x"},{"key":"ref92","doi-asserted-by":"publisher","unstructured":"YUN S, GESSNER R, DIETEL C, SCHMIEDEK U, FAN H: Enhanced ovalbumin-induced airway inflammation in CD26\u2212\/\u2212 mice. Eur J Immunol 42: 533-540, 2012. https:\/\/doi.org\/10.1002\/eji.201041038","DOI":"10.1002\/eji.201041038"},{"key":"ref93","doi-asserted-by":"publisher","unstructured":"YILMAZ I: Angiotensin-converting enzyme inhibitors induce cough. Turk Thorac J 20: 36-42, 2019. https:\/\/doi.org\/10.5152\/TurkThoracJ.2018.18014","DOI":"10.5152\/turkthoracj.2018.18014"},{"key":"ref94","doi-asserted-by":"publisher","unstructured":"YUSUF S, PITT B, DAVIS CE, HOOD WB, COHN JN: Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 325: 293-302, 1991. https:\/\/doi.org\/10.1056\/NEJM199108013250501","DOI":"10.1056\/nejm199108013250501"}],"container-title":["Physiological Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T07:21:45Z","timestamp":1695972105000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomed.cas.cz\/physiolres\/pdf\/2020\/69_S81.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,27]]},"references-count":95,"URL":"https:\/\/doi.org\/10.33549\/physiolres.934406","relation":{},"ISSN":["1802-9973","0862-8408"],"issn-type":[{"value":"1802-9973","type":"electronic"},{"value":"0862-8408","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3,27]]}}}